Rapamune and Trandate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rapamune (sirolimus) and Trandate (labetalol hydrochloride). Common drug interactions include renal failure among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Rapamune and Trandate. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Rapamune?

Rapamune has active ingredients of sirolimus. It is often used in kidney transplant. eHealthMe is studying from 13,848 Rapamune users. Check the latest studies of Rapamune.

What is Trandate?

Trandate has active ingredients of labetalol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 1,735 Trandate users. Check the latest studies of Trandate.



On Jul, 02, 2026

11 people who take Rapamune and Trandate together, and have interactions are studied.

Rapamune and Trandate drug interactions.

What are the common drug interactions of Rapamune and Trandate, by gender? *:

female:

  1. Renal failure (kidney dysfunction)
  2. Aplasia (defective development or congenital absence of an organ or tissue)
  3. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  4. Respiratory distress (difficulty in breathing)
  5. Viral infection
  6. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  7. Headache (pain in head)
  8. Kidney transplant rejection
  9. Nephrosclerosis (hardening of the kidney due to renovascular disease)
  10. Tongue oedema (swelling of tongue)

male:

  1. Abdominal pain
  2. Blood potassium decreased
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Diarrhoea
  5. Graft dysfunction
  6. Nausea (feeling of having an urge to vomit)
  7. Oedema lower limb (fluid collection in tissue of lower leg)
  8. Proteinuria present
  9. Pyrexia (fever)
  10. Renal failure acute (rapid kidney dysfunction)

What are the common drug interactions of Rapamune and Trandate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Aplasia (defective development or congenital absence of an organ or tissue)
  2. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  3. Respiratory distress (difficulty in breathing)
  4. Viral infection

20-29:

n/a

30-39:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Headache (pain in head)
  3. Kidney transplant rejection
  4. Nephrosclerosis (hardening of the kidney due to renovascular disease)
  5. Tongue oedema (swelling of tongue)

40-49:

  1. Graft dysfunction
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Proteinuria present
  4. Pyrexia (fever)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Taste disturbance
  7. White blood cell count increased
  8. Abdominal pain
  9. Blood potassium decreased
  10. Complications of transplanted kidney

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Thrombocytopenia (decrease of platelets in blood): 2 people, 18.18%
  2. Hypertensive Crisis: 2 people, 18.18%
  3. Hyperglycemia (high blood sugar): 2 people, 18.18%
  4. Sleep Disorder: 1 person, 9.09%
  5. Pharyngitis (inflammation of the pharynx, causing a sore throat): 1 person, 9.09%
  6. Muscle Aches (muscle pain): 1 person, 9.09%
  7. Joint Pain: 1 person, 9.09%
  8. Haematuria (presence of blood in urine): 1 person, 9.09%
  9. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 9.09%
  10. Abdominal Pain: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Rapamune and Trandate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rapamune and Trandate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rapamune:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Trandate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rapamune and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trandate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sirolimus and labetalol hydrochloride (the active ingredients of Rapamune and Trandate, respectively), and Rapamune and Trandate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: